Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Triumvira Immunologics" found in our extensive corporate database of over 50,000 company records.
Triumvira Immunologics, Inc. (âTriumviraâ) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current gene therapy cancer treatments, including chimeric antigen receptor (CAR) and engineered T ...
Triumvira is developing an engineered T-cell technology called the T-Cell Antigen Coupler (TAC), developed in the laboratory of Dr. Jonathan Bramson at McMaster University in Hamilton, Ontario, and is designed to activate T-cells through the T-cell receptor complex. In multiple liquid and solid tumor animal models, TAC-T cells outperform CAR-T cells, with ...
Signature Immunologics produces anti-hapten IgGs for High Performance Immunocytochemistry (HPI), targeting key small molecules in cell physiology, including fast neurotransmitter amino acids and pivotal metabolites of all cells.